2025年3月18日

TechDoctor, Kawasaki Medical University, and Philosophia Launch Long-term Joint Research on Advanced Parkinson's Disease 

Utilizing wearable devices and patient questionnaires to explore factors for QOL improvement - Aiming for optimal care model development for Parkinson's disease patients 

TechDoctor Inc. (CEO: Kazumichi Minato, Headquarters: Chuo-ku, Tokyo; hereinafter"TechDoctor"), Kawasaki Medical School (Kurashiki City, Okayama Prefecture;hereinafter "Kawasaki Medical University"), and Philosophia Inc. (CEO: Yosuke Katada, Headquarters: Osaka City, Osaka Prefecture; hereinafter "Philosophia") have commenced long-term joint research on advanced Parkinson's disease (PD) and PD-related diseases*, with cooperation from Kawasaki University of Medical Welfare and Kurashiki Neurology Clinic. In this research, TechDoctor will analyze wearable devices, patient questionnaires, and medical information to evaluate daily activity levels.

This research aims to clarify important factors for improving quality of life (QOL) and maintaining activities of daily living (ADL) in the care life of facility-resident patients and community-dwelling patients. In cooperation with the PD-specialized residential care home "PD Residence" operated by Philosophia,we aim not only to improve patient QOL but also to provide optimal care plan model cases for advanced PD patients to local communities from the perspective of efficiency and consolidation of care resources in an aging society.

*Lewy body dementia, multiple system atrophy, corticobasal degeneration, progressive supranuclear palsy, etc.

--------------------------------------------------------------------------------

1. RESEARCH BACKGROUND AND OBJECTIVES

--------------------------------------------------------------------------------

The number of Parkinson's disease patients in Japan exceeds 290,000 and is trending upward with aging. For advanced Parkinson's disease (PD) and PD-related disease patients, as the effects of drug and surgical treatments diminish,non-pharmacological interventions such as rehabilitation and environmental adjustments become important. Additionally, in advanced stages, disease diversity, complications, and lifestyle differences interact, and physical activity levels and environmental factors greatly affect patients' quality of life (QOL) and activities of daily living (ADL).

While previous research has emphasized early detection and early treatment, intervention methods for advanced stages and their effects have not been sufficiently clarified. This joint research aims to elucidate factors contributing to QOL improvement and ADL maintenance for facility-resident patients and community-dwelling patients, contributing to improvement of care and therapeutic environments in the community.

--------------------------------------------------------------------------------

2. RESEARCH OVERVIEW

--------------------------------------------------------------------------------

Research Director:

Professor Masafumi Mihara, Department of Neurology, Kawasaki Medical School

Joint Research Institutions:

Kawasaki University of Medical Welfare

Kurashiki Neurology Clinic

Philosophia Inc.

TechDoctor Inc.

Research Overview:

<Subjects>

PD and PD-related disease patients (Lewy body dementia, multiple system atrophy,corticobasal degeneration, progressive supranuclear palsy, etc.) who are outpatients at Kawasaki Medical School Hospital or residents at "PD Residence" facility

<Data Used for Research>

• Data such as pulse, activity level, and sleep obtained from wearable device

"Google Fitbit"

• Self-administered questionnaires

• Medical information and test results

<Planned Number of Cases>

Approximately 100 cases

--------------------------------------------------------------------------------

3. FUTURE PROSPECTS

--------------------------------------------------------------------------------

Through long-term data accumulation and exploratory research, we expect to contribute not only to QOL improvement for advanced Parkinson's disease (PD) patients but also to efficiency and consolidation of care resources in an aging society. We aim to explore optimal care systems for PD patients, including appropriate environmental adjustments, care plan development, and setting appropriate intervention amounts, and to return model cases to local communities.

--------------------------------------------------------------------------------

ABOUT KAWASAKI MEDICAL SCHOOL DEPARTMENT OF NEUROLOGY

--------------------------------------------------------------------------------

With the aging of society, patients with dementia and neurodegenerative diseases such as Parkinson's disease are rapidly increasing. The Kawasaki Medical School Department of Neurology has constructed registries combining clinical indicators, imaging tests, and biochemical markers, and is working on various research projects themed "Neuroscience × Rehabilitation," including improving exercise habits through digital device utilization and optimizing medical care. With a mission to empathize with patients' concerns and contribute to improving quality of life, we aim to realize better medicine through clinical practice, research, and education.

--------------------------------------------------------------------------------

ABOUT PHILOSOPHIA INC. / PD RESIDENCE

--------------------------------------------------------------------------------

Under the philosophy of "Living well," Philosophia Inc. collaborates with medical and care professionals to provide home services and facility services.

PD Residence is a residential care home for the elderly specializing in neurological intractable diseases including Parkinson's disease. While spending daily life in a space like one's own home, patients can approach treatment and care with support from nursing, care, and rehabilitation experts.

--------------------------------------------------------------------------------

ABOUT TECHDOCTOR INC.

--------------------------------------------------------------------------------

Under the vision "Towards an era where data improves well-being," TechDoctor Inc. develops and operates the digital biomarker development platform "SelfBase (Self-Base)" for medical, pharmaceutical, food-related companies, and research institutions, and the data platform "Health Portal" that realizes development of healthcare services, health measures, and program medical devices (SaMD).

We contribute to improving the health and well-being of all people by combining a medical perspective based on research activities and technology to analyze large amounts of data collected from wearable devices and medical devices using

AI and machine learning.

Company Name: TechDoctor Inc.

Website: https://www.technology-doctor.com/

Founded: June 21, 2019

Location: Kyobashi Ed-Grand 4F, 2-2-1 Kyobashi, Chuo-ku, Tokyo

CEO: Kazumichi Minato

Business: Development and operation of digital biomarker development platform

"SelfBase," provision of digital medical solutions

ISMS (Information Security Management System) international standard

"ISO/IEC 27001:2022" certification obtained.